{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T12:00:47Z","timestamp":1792670447025,"version":"4.5.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,7,23]],"date-time":"2015-07-23T00:00:00Z","timestamp":1437609600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Orthopaedic Translation"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.jot.2015.07.004","type":"journal-article","created":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T22:47:24Z","timestamp":1439419644000},"page":"166-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Multimodal imaging of bone metastases: From preclinical to clinical applications"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2737-5526","authenticated-orcid":false,"given":"Stephan","family":"Ellmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Kuwert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Uder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"B\u00e4uerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jot.2015.07.004_bib1","doi-asserted-by":"crossref","first-page":"S6243","DOI":"10.1158\/1078-0432.CCR-06-0931","article-title":"Clinical features of metastatic bone disease and risk of skeletal morbidity","volume":"12","author":"Coleman","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jot.2015.07.004_bib2","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/cncr.26512","article-title":"Retrospective analysis of antitumor effects of zoledronic acid in breast cancer patients with bone-only metastases","volume":"118","author":"Niikura","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.jot.2015.07.004_bib3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S0959-8049(99)00331-7","article-title":"Risk of complications from bone metastases in breast cancer. implications for management","volume":"36","author":"Plunkett","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jot.2015.07.004_bib4","first-page":"69","article-title":"Scientific and clinical aspects of radiotherapy in the relief of bone pain","volume":"7","author":"Hoskin","year":"1988","journal-title":"Cancer Surv"},{"key":"10.1016\/j.jot.2015.07.004_bib5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1200\/JCO.2006.09.5281","article-title":"Palliative radiotherapy trials for bone metastases: a systematic review","volume":"25","author":"Chow","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib6","first-page":"CD004721","article-title":"Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy \u2013 a systematic review of the randomised trials","author":"Sze","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jot.2015.07.004_bib7","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1093\/annonc\/mdg367","article-title":"Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases","volume":"14","author":"Body","year":"2003","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S1470-2045(14)70474-7","volume":"15","author":"Hoskin","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3816\/CBC.2000.n.003","article-title":"Treatment of metastatic bone disease in breast cancer: bisphosphonates","volume":"1","author":"Diel","year":"2000","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.jot.2015.07.004_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jot.2015.07.004_bib11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ejphar.2013.01.079","article-title":"Molecular imaging for monitoring treatment response in breast cancer patients","volume":"717","author":"Bensch","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jot.2015.07.004_bib12","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1007\/s00330-009-1443-1","article-title":"Imaging response to systemic therapy for bone metastases","volume":"19","author":"B\u00e4uerle","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib13","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/sj.bjc.6605546","article-title":"Tumour response interpretation with new tumour response criteria vs the World Health Organisation criteria in patients with bone-only metastatic breast cancer","volume":"102","author":"Hamaoka","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jot.2015.07.004_bib14","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1200\/JCO.2004.08.181","article-title":"Bone imaging in metastatic breast cancer","volume":"22","author":"Hamaoka","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1053\/j.semnuclmed.2013.02.002","article-title":"Imaging breast cancer bone metastases: current status and future directions","volume":"43","author":"Glendenning","year":"2013","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib16","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1007\/s00330-013-2792-3","article-title":"MRI for response assessment in metastatic bone disease","volume":"23","author":"Lecouvet","year":"2013","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib17","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/jbmr.68","article-title":"Of mice and (wo)men: mouse models of breast cancer metastasis to bone","volume":"25","author":"Goldstein","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jot.2015.07.004_bib18","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s10555-012-9378-4","article-title":"Mouse models of breast cancer metastasis to bone","volume":"31","author":"Kretschmann","year":"2012","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.jot.2015.07.004_bib19","first-page":"485","article-title":"Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice","volume":"1","author":"Kakiuchi","year":"2003","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.jot.2015.07.004_bib20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ijc.20840","article-title":"Characterisation of a rat model with site-specific bone metastasis induced by MDA-MB-231 breast cancer cells and its application to the effects of an antibody against bone sialoprotein","volume":"115","author":"B\u00e4uerle","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jot.2015.07.004_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2010.08.004","article-title":"TGF-beta in cancer and bone: implications for treatment of bone metastases","volume":"48","author":"Juarez","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jot.2015.07.004_bib22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0093-7754(01)90263-5","article-title":"Preclinical studies with zoledronic acid and other bisphosphonates: impact on the bone microenvironment","volume":"28","author":"Mundy","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10585-007-9127-1","article-title":"Inhibition of RANKL blocks skeletal tumor progression and improves survival in a mouse model of breast cancer bone metastasis","volume":"25","author":"Canon","year":"2008","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.jot.2015.07.004_bib24","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1023\/A:1006689719505","article-title":"A novel orthotopic model of breast cancer metastasis to bone","volume":"17","author":"Lelekakis","year":"1999","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.jot.2015.07.004_bib25","doi-asserted-by":"crossref","first-page":"6130","DOI":"10.1158\/0008-5472.CAN-04-1408","article-title":"A mouse model of human breast cancer metastasis to human bone","volume":"65","author":"Kuperwasser","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.jot.2015.07.004_bib26","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejrad.2008.10.020","article-title":"Imaging anti-angiogenic treatment response with DCE-VCT, DCE-MRI and DWI in an animal model of breast cancer bone metastasis","volume":"73","author":"B\u00e4uerle","year":"2010","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1593\/neo.08220","article-title":"Bevacizumab inhibits breast cancer-induced osteolysis, surrounding soft tissue metastasis, and angiogenesis in rats as visualized by VCT and MRI","volume":"10","author":"B\u00e4uerle","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.jot.2015.07.004_bib28","first-page":"e4178","article-title":"Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound","volume":"14","author":"B\u00e4uerle","year":"2012","journal-title":"J Vis Exp"},{"key":"10.1016\/j.jot.2015.07.004_bib29","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/nbm.1153","article-title":"In\u00a0vivo mouse imaging and spectroscopy in drug discovery","volume":"20","author":"Beckmann","year":"2007","journal-title":"NMR Biomed"},{"key":"10.1016\/j.jot.2015.07.004_bib30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1053\/j.semnuclmed.2010.12.003","article-title":"Imaging devices for use in small animals","volume":"41","author":"Koba","year":"2011","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib31","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1002\/jcb.23432","article-title":"In\u00a0vivo magnetic resonance imaging tracking of SPIO-labeled human umbilical cord mesenchymal stem cells","volume":"113","author":"Hu","year":"2012","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.jot.2015.07.004_bib32","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.cbpa.2006.06.028","article-title":"Molecular imaging strategies for drug discovery and development","volume":"10","author":"Gross","year":"2006","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jot.2015.07.004_bib33","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1097\/RLI.0b013e31824f635a","article-title":"Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases","volume":"47","author":"Merz","year":"2012","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib34","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2217\/fon.12.33","article-title":"Preclinical imaging of the cellular and molecular events in the multistep process of bone metastasis","volume":"8","author":"van der Horst","year":"2012","journal-title":"Future Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib35","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1513\/pats.200508-079DS","article-title":"Instrumentation for molecular imaging in preclinical research: Micro-PET and Micro-SPECT","volume":"2","author":"Chatziioannou","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.jot.2015.07.004_bib36","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.semradonc.2010.11.004","article-title":"The promise and pitfalls of positron emission tomography and single-photon emission computed tomography molecular imaging-guided radiation therapy","volume":"21","author":"Wahl","year":"2011","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib37","doi-asserted-by":"crossref","first-page":"e82709","DOI":"10.1371\/journal.pone.0082709","article-title":"Microstructural, densitometric and metabolic variations in bones from rats with normal or altered skeletal states","volume":"8","author":"Luu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jot.2015.07.004_bib38","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/cmmi.435","article-title":"A novel PET tracer for the imaging of alphavbeta3 and alphavbeta5 integrins in experimental breast cancer bone metastases","volume":"6","author":"Muhlhausen","year":"2011","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.jot.2015.07.004_bib39","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/path.2656","article-title":"Bioluminescent imaging: a critical tool in pre-clinical oncology research","volume":"220","author":"O'Neill","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.jot.2015.07.004_bib40","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1096\/fj.08-126920","article-title":"Multimodality imaging of TGFbeta signaling in breast cancer metastases","volume":"23","author":"Serganova","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.jot.2015.07.004_bib41","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cbpa.2009.09.029","article-title":"Near-infrared fluorescence: application to in\u00a0vivo molecular imaging","volume":"14","author":"Hilderbrand","year":"2010","journal-title":"Curr Opin Chem Biol"},{"key":"10.1016\/j.jot.2015.07.004_bib42","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1038\/nbt1201-1148","article-title":"In\u00a0vivo near-infrared fluorescence imaging of osteoblastic activity","volume":"19","author":"Zaheer","year":"2001","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jot.2015.07.004_bib43","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1359\/jbmr.070504","article-title":"Noninvasive optical detection of bone mineral","volume":"22","author":"Kozloff","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jot.2015.07.004_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nbt767","article-title":"Long-term multiple color imaging of live cells using quantum dot bioconjugates","volume":"21","author":"Jaiswal","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jot.2015.07.004_bib45","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/89126","article-title":"In\u00a0vivo molecular target assessment of matrix metalloproteinase inhibition","volume":"7","author":"Bremer","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jot.2015.07.004_bib46","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.bone.2010.07.027","article-title":"Optical advances in skeletal imaging applied to bone metastases","volume":"48","author":"Snoeks","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.jot.2015.07.004_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0001-2998(97)80043-8","article-title":"Diagnostic bone scanning in oncology","volume":"27","author":"Krasnow","year":"1997","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib48","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1046\/j.1464-410X.2003.04362.x","article-title":"Quantitative evaluation of bone metastases in patients with advanced prostate cancer during systemic treatment","volume":"92","author":"Yahara","year":"2003","journal-title":"BJU Int"},{"key":"10.1016\/j.jot.2015.07.004_bib49","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1148\/radiology.134.3.7355226","article-title":"Comparison of bone scintigraphy and radiography in multiple myeloma","volume":"134","author":"Woolfenden","year":"1980","journal-title":"Radiology"},{"key":"10.1016\/j.jot.2015.07.004_bib50","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1007\/s00330-011-2173-8","article-title":"Assessing response in bone metastases in prostate cancer with diffusion weighted MRI","volume":"21","author":"Messiou","year":"2011","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib51","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1148\/radiology.146.2.6294738","article-title":"Comparative value of bone scintigraphy and radiography in monitoring tumor response in systemically treated prostatic carcinoma","volume":"146","author":"Levenson","year":"1983","journal-title":"Radiology"},{"key":"10.1016\/j.jot.2015.07.004_bib52","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.ejca.2014.07.002","article-title":"Monitoring the response of bone metastases to treatment with Magnetic Resonance Imaging and nuclear medicine techniques: a review and position statement by the European Organisation for Research and Treatment of Cancer imaging group","volume":"50","author":"Lecouvet","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jot.2015.07.004_bib53","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0009-9260(77)80135-9","article-title":"Problems and limitations of bone scanning with the 99Tcm-phosphates","volume":"28","author":"Citrin","year":"1977","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00361858","article-title":"Radiographic evaluation of therapeutic response in bony metastases of breast cancer","volume":"7","author":"Libshitz","year":"1981","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib55","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S0305-7372(96)90021-3","article-title":"Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment","volume":"22","author":"Vinholes","year":"1996","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jot.2015.07.004_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00361657","article-title":"Computed tomography or magnetic resonance for evaluating the solitary tumor or tumor-like lesion of bone?","volume":"17","author":"Sundaram","year":"1988","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib57","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1148\/radiology.140.3.7280245","article-title":"Detection of bone-marrow metastases using quantitative computed tomography","volume":"140","author":"Helms","year":"1981","journal-title":"Radiology"},{"key":"10.1016\/j.jot.2015.07.004_bib58","first-page":"488","article-title":"X-ray computed tomography or MRI in the assessment of bone tumor extension","volume":"117","author":"Poitout","year":"1991","journal-title":"Chirurgie"},{"key":"10.1016\/j.jot.2015.07.004_bib59","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/BF00351751","article-title":"Osteodensitometry of vertebral metastases after radiotherapy using quantitative computed tomography","volume":"18","author":"Reinbold","year":"1989","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0009-9260(87)80207-6","article-title":"Comparison of computed tomography and conventional radiology in the assessment of treatment response of lytic bony metastases in patients with carcinoma of the breast","volume":"38","author":"Bellamy","year":"1987","journal-title":"Clin Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib61","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1148\/radiol.2363041220","article-title":"Use of an automatic exposure control mechanism for dose optimization in multi-detector row CT examinations: clinical evaluation","volume":"237","author":"Mulkens","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jot.2015.07.004_bib62","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00256-010-0963-8","article-title":"A meta-analysis of 18FDG-PET, MRI and bone scintigraphy for diagnosis of bone metastases in patients with breast cancer","volume":"40","author":"Liu","year":"2011","journal-title":"Skeletal Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib63","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1200\/JCO.2006.09.2940","article-title":"Magnetic resonance imaging of the axial skeleton for detecting bone metastases in patients with high-risk prostate cancer: diagnostic and cost-effectiveness and comparison with current detection strategies","volume":"25","author":"Lecouvet","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0169-5002(99)00105-1","article-title":"Detection of bone marrow metastases of small cell lung cancer with magnetic resonance imaging: early diagnosis before destruction of osseous structure and implications for staging","volume":"27","author":"Imamura","year":"2000","journal-title":"Lung Cancer"},{"key":"10.1016\/j.jot.2015.07.004_bib65","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejrad.2007.10.021","article-title":"Comprehensive imaging of tumor recurrence in breast cancer patients using whole-body MRI at 1.5 and 3 T compared to FDG-PET-CT","volume":"65","author":"Schmidt","year":"2008","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib66","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1177\/028418519303400603","article-title":"Detection of breast cancer metastases in the cervical spine","volume":"34","author":"Petren-Mallmin","year":"1993","journal-title":"Acta Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/pros.20280","article-title":"Magnetic resonance imaging of the axial skeleton enables objective measurement of tumor response on prostate cancer bone metastases","volume":"65","author":"Tombal","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.jot.2015.07.004_bib68","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2214\/AJR.07.2635","article-title":"Whole-body MRI versus whole-body MDCT for staging of multiple myeloma","volume":"190","author":"Baur-Melnyk","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jot.2015.07.004_bib69","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00330-003-1968-7","article-title":"Comparison of whole-body MRI with automatic moving table technique and bone scintigraphy for screening for bone metastases in patients with breast cancer","volume":"14","author":"Engelhard","year":"2004","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib70","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1158\/1078-0432.CCR-06-0061","article-title":"Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma","volume":"13","author":"Hillengass","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jot.2015.07.004_bib71","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/jmri.20349","article-title":"Dynamic contrast-enhanced MRI for assessing the disease activity of multiple myeloma: a comparative study with histology and clinical markers","volume":"22","author":"Nosas-Garcia","year":"2005","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.jot.2015.07.004_bib72","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1055\/s-2005-858362","article-title":"Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma","volume":"177","author":"Wasser","year":"2005","journal-title":"Rofo"},{"key":"10.1016\/j.jot.2015.07.004_bib73","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s00259-010-1399-z","article-title":"Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET\/CT for whole-body breast cancer staging","volume":"37","author":"Heusner","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jot.2015.07.004_bib74","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1148\/radiol.2522090263","article-title":"Diffusion-weighted MR imaging: adjunct or alternative to T1-weighted MR imaging for prostate carcinoma bone metastases?","volume":"252","author":"Lecouvet","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/j.jot.2015.07.004_bib75","doi-asserted-by":"crossref","first-page":"3524","DOI":"10.1158\/0008-5472.CAN-06-4236","article-title":"An imaging biomarker of early treatment response in prostate cancer that has metastasized to the bone","volume":"67","author":"Lee","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.jot.2015.07.004_bib76","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1148\/radiol.10092469","article-title":"Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps\u2013initial observations","volume":"257","author":"Reischauer","year":"2010","journal-title":"Radiology"},{"key":"10.1016\/j.jot.2015.07.004_bib77","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0001-2998(87)80037-5","article-title":"Bone SPECT","volume":"17","author":"Collier","year":"1987","journal-title":"Semin Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib78","first-page":"633","article-title":"Evaluation of the skeletal kinetics of fluorine-18-fluoride ion with PET","volume":"33","author":"Hawkins","year":"1992","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib79","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1200\/JCO.1998.16.10.3375","article-title":"Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions","volume":"16","author":"Cook","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib80","first-page":"287","article-title":"The detection of bone metastases in patients with high-risk prostate cancer: 99mTc-MDP Planar bone scintigraphy, single- and multi-field-of-view SPECT, 18F-fluoride PET, and 18F-fluoride PET\/CT","volume":"47","author":"Even-Sapir","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib81","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1148\/radiology.199.3.8638000","article-title":"Metastatic prostate cancer: initial findings of PET with 2-deoxy-2-[F-18]fluoro-D-glucose","volume":"199","author":"Shreve","year":"1996","journal-title":"Radiology"},{"key":"10.1016\/j.jot.2015.07.004_bib82","first-page":"431","article-title":"Accuracy of whole-body fluorine-18-FDG PET for the detection of recurrent or metastatic breast carcinoma","volume":"39","author":"Moon","year":"1998","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib83","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1200\/JCO.1998.16.1.173","article-title":"Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy","volume":"16","author":"Sugawara","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib84","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1097\/RLU.0b013e3182996138","article-title":"18F sodium fluoride PET\/CT detects osseous metastases from breast cancer missed on FDG PET\/CT with marrow rebound","volume":"38","author":"Avery","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib85","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.bone.2011.09.053","article-title":"Clinical utility of (18)F-fluoride PET\/CT in benign and malignant bone diseases","volume":"50","author":"Li","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.jot.2015.07.004_bib86","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2214\/AJR.13.12158","article-title":"Molecular imaging in oncology: (18)F-sodium fluoride PET imaging of osseous metastatic disease","volume":"203","author":"Mick","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jot.2015.07.004_bib87","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00259-006-0110-x","article-title":"Comparison of the pharmacokinetics of 68Ga-DOTATOC and [18F]FDG in patients with metastatic neuroendocrine tumours scheduled for 90Y-DOTATOC therapy","volume":"33","author":"Koukouraki","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jot.2015.07.004_bib88","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2967\/jnumed.108.053421","article-title":"68Ga-DOTA-Tyr3-octreotide PET for assessing response to somatostatin-receptor-mediated radionuclide therapy","volume":"50","author":"Gabriel","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib89","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1007\/s00259-004-1462-8","article-title":"PET with [18F]fluorothymidine for imaging of primary breast cancer: a pilot study","volume":"31","author":"Smyczek-Gargya","year":"2004","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jot.2015.07.004_bib90","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11307-005-0029-9","article-title":"Usefulness of 3\u2032-[F-18]fluoro-3\u2032-deoxythymidine with positron emission tomography in predicting breast cancer response to therapy","volume":"8","author":"Pio","year":"2006","journal-title":"Mol Imaging Biol"},{"key":"10.1016\/j.jot.2015.07.004_bib91","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s00259-007-0379-4","article-title":"Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3\u2032-deoxy-3\u2032-[18F]fluorothymidine positron emission tomography","volume":"34","author":"Kenny","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jot.2015.07.004_bib92","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1200\/JCO.2005.04.3810","article-title":"Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer","volume":"24","author":"Linden","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jot.2015.07.004_bib93","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1210\/mend-5-11-1571","article-title":"Estrogen receptor variants in clinical breast cancer","volume":"5","author":"McGuire","year":"1991","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jot.2015.07.004_bib94","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/clpt.2010.12","article-title":"Biodistribution of 89Zr-trastuzumab and PET imaging of HER2-positive lesions in patients with metastatic breast cancer","volume":"87","author":"Dijkers","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jot.2015.07.004_bib95","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/s00259-013-2374-2","article-title":"PSMA as a target for radiolabelled small molecules","volume":"40","author":"Eder","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jot.2015.07.004_bib96","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00259-013-2525-5","article-title":"Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET\/CT for the diagnosis of recurrent prostate cancer","volume":"41","author":"Afshar-Oromieh","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jot.2015.07.004_bib97","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1076-6332(03)80461-0","article-title":"Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy","volume":"9","author":"Stafford","year":"2002","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib98","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-2006-932181","article-title":"Usefulness of (18)F-fluorodeoxyglucose PET for radiosurgery planning and response monitoring in patients with recurrent spinal metastasis","volume":"49","author":"Gwak","year":"2006","journal-title":"Minim Invasive Neurosurg"},{"key":"10.1016\/j.jot.2015.07.004_bib99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s002590050359","article-title":"Positron emission tomographic assessment of \u201cmetabolic flare\u201d to predict response of metastatic breast cancer to antiestrogen therapy","volume":"26","author":"Dehdashti","year":"1999","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0959-8049(99)00229-4","article-title":"Measurement of clinical and subclinical tumour response using [18F]-fluorodeoxyglucose and positron emission tomography: review and 1999 EORTC recommendations. European Organization for Research and Treatment of Cancer (EORTC) PET Study Group","volume":"35","author":"Young","year":"1999","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jot.2015.07.004_bib101","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/cam4.33","article-title":"18-FDG PET\/CT assessment of basal cell carcinoma with vismodegib","volume":"1","author":"Thacker","year":"2012","journal-title":"Cancer Med"},{"key":"10.1016\/j.jot.2015.07.004_bib102","first-page":"1102","article-title":"SPECT-guided CT for evaluating foci of increased bone metabolism classified as indeterminate on SPECT in cancer patients","volume":"47","author":"Romer","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib103","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1148\/radiol.2471070567","article-title":"Bone metastases in patients with metastatic breast cancer: morphologic and metabolic monitoring of response to systemic therapy with integrated PET\/CT","volume":"247","author":"Tateishi","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/j.jot.2015.07.004_bib104","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/ajh.22044","article-title":"The role of 18F-FDG PET\/CT imaging in Waldenstrom macroglobulinemia","volume":"86","author":"Banwait","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jot.2015.07.004_bib105","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2967\/jnumed.112.104893","article-title":"Utility of 18F-fluoride PET\/CT and 18F-FDG PET\/CT in the detection of bony metastases in heightened-risk head and neck cancer patients","volume":"53","author":"Chan","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib106","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1016\/j.ejrad.2011.12.020","article-title":"Detection of metastatic bone lesions in breast cancer patients: fused (18)F-Fluoride-PET\/MDCT has higher accuracy than MDCT. Preliminary experience","volume":"81","author":"Piccardo","year":"2012","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.jot.2015.07.004_bib107","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2967\/jnumed.109.071571","article-title":"Quantitative accuracy of clinical 99mTc SPECT\/CT using ordered-subset expectation maximization with 3-dimensional resolution recovery, attenuation, and scatter correction","volume":"51","author":"Zeintl","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/j.jot.2015.07.004_bib108","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/2191-219X-3-45","article-title":"Quantification of 99mTc-DPD concentration in the lumbar spine with SPECT\/CT","volume":"3","author":"Cachovan","year":"2013","journal-title":"EJNMMI Res"},{"key":"10.1016\/j.jot.2015.07.004_bib109","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.bjc.6605825","article-title":"Assessment of therapeutic response in patients with metastatic skeletal disease: suggested modifications for the MDA response classification criteria","volume":"103","author":"Vassiliou","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jot.2015.07.004_bib110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.5603\/NMR.2011.00024","article-title":"Bone metastases diagnosis possibilities in studies with the use of 18F-NaF and 18F-FDG","volume":"14","author":"Tarnawska-Pierscinska","year":"2011","journal-title":"Nucl Med Rev Cent East Eur"},{"key":"10.1016\/j.jot.2015.07.004_bib111","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/annonc\/mdp028","article-title":"Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?","volume":"20","author":"Simmons","year":"2009","journal-title":"Ann Oncol"}],"container-title":["Journal of Orthopaedic Translation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214031X15000571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214031X15000571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:38:41Z","timestamp":1761993521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214031X15000571"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":111,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2214031X15000571"],"URL":"https:\/\/doi.org\/10.1016\/j.jot.2015.07.004","relation":{},"ISSN":["2214-031X"],"issn-type":[{"value":"2214-031X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multimodal imaging of bone metastases: From preclinical to clinical applications","name":"articletitle","label":"Article Title"},{"value":"Journal of Orthopaedic Translation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jot.2015.07.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier (Singapore) Pte Ltd.","name":"copyright","label":"Copyright"}]}}